↓ Skip to main content

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

patent
1 patent

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
3 Mendeley